Gene · 2204
Papers1,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy. | Kidney Int Rep | 2023 | 38106605 | PubTator, text mining | PubMed |
| Targeting the myeloid microenvironment in neuroblastoma. | J Exp Clin Cancer Res | 2023 | 38087370 | PubTator, text mining | PubMed |
| Tear Fluid Inflammatory Proteome Analysis Highlights Similarities Between Keratoconus and Allergic Conjunctivitis. | Invest Ophthalmol Vis Sci | 2023 | 38064228 | PubTator, text mining | PubMed |
| Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer. | J Immunother Cancer | 2023 | 38056896 | PubTator, text mining | PubMed |
| Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients. | Clin Kidney J | 2023 | 38053974 | PubTator, text mining | PubMed |
| Impact of intestinal microenvironments in obesity and bariatric surgery on shaping macrophages. | Immunometabolism (Cobham) | 2023 | 38037591 | PubTator, text mining | PubMed |
| Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases. | Front Immunol | 2023 | 38022571 | PubTator, text mining | PubMed |
| Impact of Fc receptors and host characteristics on myeloid phagocytic response to rituximab-treated 3D-cultured B-cell lymphoma. | Immunother Adv | 2023 | 38020313 | PubTator, text mining | PubMed |
| Proteomics and metabolomics analyses of Streptococcus agalactiae isolates from human and animal sources. | Sci Rep | 2023 | 38017083 | PubTator, text mining | PubMed |
| Single cell transcriptomics shows that malaria promotes unique regulatory responses across multiple immune cell subsets. | Nat Commun | 2023 | 37968278 | PubTator, text mining | PubMed |
| Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study. | Front Immunol | 2023 | 37965313 | PubTator, text mining | PubMed |
| Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine. | J Virol | 2023 | 37902399 | PubTator, text mining | PubMed |
| Machine learning-based identification of CYBB and FCAR as potential neutrophil extracellular trap-related treatment targets in sepsis. | Front Immunol | 2023 | 37901228 | PubTator, text mining | PubMed |
| My Name Is Legion, for We Are Many-The Complex Community of Antibody Receptors. | Int J Mol Sci | 2023 | 37894907 | PubTator, text mining | PubMed |
| Immune Thrombosis: Exploring the Significance of Immune Complexes and NETosis. | Biology (Basel) | 2023 | 37887042 | PubTator, text mining | PubMed |
| Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial. | Nat Commun | 2023 | 37875494 | PubTator, text mining | PubMed |
| SIgA structures bound to Streptococcus pyogenes M4 and human CD89 provide insights into host-pathogen interactions. | Nat Commun | 2023 | 37872175 | PubTator, text mining | PubMed |
| The yin and yang of B cells in a constant state of battle: intestinal inflammation and inflammatory bowel disease. | Front Immunol | 2023 | 37849749 | PubTator, text mining | PubMed |
| New insights into intestinal macrophages in necrotizing enterocolitis: the multi-functional role and promising therapeutic application. | Front Immunol | 2023 | 37841247 | PubTator, text mining | PubMed |
| Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses. | PLoS Pathog | 2023 | 37812640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2204/papers?page=5